Skip to main content
. 2013 Dec 1;6(1):28–42.

Table 4.

Selective genes differentially expressed after MPA treatment

Genes R12h R24h R48h R72h p-12h p-24h p-48h p-72h
ABCA12 1.0 2.3 5.4 4.2 9.7E-01 3.7E-09 8.1E-15 2.6E-13
ABCB9 2.3 3.4 4.3 2.9 6.2E-09 3.7E-12 1.4E-13 5.1E-11
ATF3 5.6 6.3 7.0 6.8 3.8E-13 2.0E-14 6.5E-15 1.1E-14
CDH10 1.5 3.1 4.8 7.4 2.6E-03 8.3E-10 2.8E-12 5.0E-14
CEACAM1 2.8 6.0 5.3 2.9 1.9E-10 4.2E-15 1.3E-14 6.0E-11
CITED2 2.2 2.2 4.6 3.5 1.5E-06 6.8E-07 1.9E-11 7.8E-10
CYR61 2.7 3.5 4.9 3.5 8.1E-09 5.3E-11 8.3E-13 7.6E-11
GRIN2C 5.9 8.3 9.6 10.6 6.4E-14 4.3E-16 1.3E-16 5.8E-17
NOS3 1.1 1.6 4.7 6.5 8.3E-01 4.3E-05 4.8E-14 1.9E-15
NPPB 2.9 8.9 17.0 11.6 1.4E-07 4.0E-13 3.1E-15 6.5E-14
RN7SK 3.6 12.1 81.6 176.9 3.7E-11 1.2E-16 6.2E-22 1.5E-23
RNA28S5 1.0 1.2 15.9 40.4 9.2E-01 3.6E-01 3.1E-15 2.9E-17
SLC30A1 5.3 6.3 3.8 3.4 7.6E-13 2.1E-14 6.3E-12 4.4E-11
SLC30A1 4.6 5.5 3.9 4.0 2.4E-13 6.5E-15 3.5E-13 3.7E-13
SLC31A2 2.8 4.1 2.9 3.4 4.9E-11 4.4E-14 7.3E-12 1.0E-12
SMAD3 1.6 4.3 3.6 2.7 1.5E-04 1.2E-12 1.5E-11 1.0E-09
TP53I3 5.4 12.0 11.0 7.7 1.2E-13 4.2E-17 5.7E-17 8.6E-16
TP53INP1 3.2 4.2 4.3 4.0 7.1E-11 6.0E-13 4.5E-13 1.8E-12
TXNIP 2.7 3.1 5.5 6.1 2.5E-09 9.3E-11 7.5E-14 3.1E-14
ARRB1 0.18 0.20 0.19 0.18 3.0E-14 8.1E-15 5.1E-15 2.8E-15
CHN2 0.38 0.37 0.27 0.32 2.4E-09 4.1E-10 3.5E-12 6.0E-11
CLDN2 0.53 0.37 0.23 0.22 5.9E-07 2.2E-10 2.0E-13 1.7E-13
D2HGDH 0.71 0.29 0.20 0.23 1.2E-03 3.6E-12 2.3E-14 2.0E-13
ESRRG 0.29 0.28 0.26 0.29 1.5E-08 4.7E-09 2.7E-09 1.3E-08
HSPA5 0.22 0.18 0.25 0.28 1.8E-12 2.8E-14 1.4E-12 8.2E-12
IGFBP5 0.14 0.10 0.10 0.09 1.2E-13 9.6E-16 1.0E-15 8.6E-16
INF2 0.25 0.22 0.24 0.24 4.9E-11 4.4E-12 1.1E-11 1.7E-11
LRP8 0.43 0.31 0.20 0.27 1.9E-08 4.6E-11 2.0E-13 7.2E-12
NAV2 0.18 0.17 0.13 0.12 1.3E-12 1.7E-13 1.0E-14 6.6E-15
PAGE4 0.63 0.34 0.14 0.10 2.9E-04 9.0E-10 2.3E-14 1.9E-15
PDGFRA 0.41 0.28 0.23 0.16 7.3E-09 5.1E-12 4.7E-13 1.1E-14
PLA2G2A 0.68 0.41 0.29 0.29 3.6E-03 5.6E-08 2.3E-10 4.4E-10
PPARG 0.56 0.33 0.28 0.35 2.2E-06 4.2E-11 2.3E-12 1.3E-10
PRKCA 0.31 0.35 0.28 0.27 3.7E-11 8.4E-11 2.8E-12 3.5E-12
SNCAIP 0.31 0.18 0.12 0.14 1.7E-10 7.3E-14 1.3E-15 5.4E-15
AURKA 0.73 0.68 0.64 0.54 1.3E-03 1.2E-04 1.6E-05 1.4E-07
AURKB 0.96 0.82 0.50 0.51 9.1E-01 1.8E-01 3.3E-06 5.0E-06
FOXM1 0.79 0.65 0.42 0.54 1.3E-01 1.6E-03 1.5E-07 2.1E-05
BOP1 0.48 0.34 0.41 0.57 3.4E-07 3.9E-10 8.6E-09 9.8E-06
BUB1 0.66 0.52 0.39 0.42 1.8E-04 2.7E-07 6.4E-10 2.7E-09
BUB1B 0.61 0.66 0.62 0.56 3.0E-05 1.9E-04 2.8E-05 2.5E-06
SRC 0.97 0.82 0.67 0.56 9.2E-01 1.4E-01 9.0E-04 1.1E-05

R12h, R24h, R48h and R72h denote gene expression ratios at the respective time point over untreated control (0h). p-12h, p-24h, p48h and p72h denote p-values for the comparison between untreated control (0h) and the respective time point.